Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis

PROBLEM: New drugs for infectious diseases often need to be evaluated in low-resource settings. While people working in such settings often provide high-quality care and perform operational research activities, they generally have less experience in conducting clinical trials designed for drug appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tupasi, Thelma, Gupta, Rajesh, Danilovits, Manfred, Cirule, Andra, Sanchez-Garavito, Epifanio, Xiao, Heping, Cabrera-Rivero, Jose L, Vargas-Vasquez, Dante E, Gao, Mengqiu, Awad, Mohamed, Gentry, Leesa M, Geiter, Lawrence J, Wells, Charles D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2016
Materias:
Lessons from the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750433/
https://www.ncbi.nlm.nih.gov/pubmed/26908964
http://dx.doi.org/10.2471/BLT.15.154997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750433/
https://www.ncbi.nlm.nih.gov/pubmed/26908964
http://dx.doi.org/10.2471/BLT.15.154997

Ejemplares similares